583 Efficacy and safety of litifilimab in cutaneous lupus erythematosus (CLE): Phase 2/3 AMETHYST study design
In: Journal of investigative dermatology, Jg. 143 (2023), Heft S, S. S100
Online
serialPeriodical
Zugriff:
Titel: |
583 Efficacy and safety of litifilimab in cutaneous lupus erythematosus (CLE): Phase 2/3 AMETHYST study design
|
---|---|
Autor/in / Beteiligte Person: | Werth, V.P. ; Merola, J.F. ; Chong, B.F. ; Nyberg, F. ; Morand, E.F. ; Galimberti, R. ; Zhu, W. ; Li, Q. ; Sacks, J. ; Yang, W. ; Schindelar, M. ; Barbey, C. |
Link: | |
Zeitschrift: | Journal of investigative dermatology, Jg. 143 (2023), Heft S, S. S100 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 0022-202X (print) |
Sonstiges: |
|